Kathryn Stein - Dec 4, 2023 Form 4 Insider Report for Genpact LTD (G)

Role
Senior Vice President
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Kathryn Stein
Stock symbol
G
Transactions as of
Dec 4, 2023
Transactions value $
-$916,464
Form type
4
Date filed
12/6/2023, 04:16 PM
Previous filing
Mar 17, 2023
Next filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Options Exercise $1.08M +39.1K +37.53% $27.70 143K Dec 4, 2023 Direct F1
transaction G Common Shares Sale -$1.36M -39.1K -27.29% $34.85 104K Dec 4, 2023 Direct F2
transaction G Common Shares Sale -$637K -18.3K -17.57% $34.85 85.8K Dec 4, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction G Employee Stock Option (Right to Buy) Options Exercise $0 -39.1K -31.72% $0.00 84.1K Dec 4, 2023 Common Shares 39.1K $27.70 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 213 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 17, 2023. The reporting person currently holds a total of 3,337 shares under the ESPP.
F2 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.66 to $35.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $34.67 to $34.99. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The option vested 50% on January 10, 2022 and the remainder will vest on January 10, 2024, subject to the reporting person's continued service through such date.